Results 131 to 140 of about 5,163,498 (211)

Polo-like kinase Cdc5 orchestrates Cdk1 regulation via Swe1 and Mih1 during meiotic prophase I exit. [PDF]

Commun Biol
González-Arranz S, Acosta I, Gil-Torres I, Queralt E, Santos B, San-Segundo PA.   +5 more
europepmc   +1 more source

Nitidine chloride suppresses polo-like kinase 1 via MYCN-associated transcriptional regulation in colorectal cancer: a multi-omics and spatial transcriptomics study. [PDF]

Front Oncol
Huang XJ, Mo LH, Wu KJ, He RQ, Li H, Chen G, Liu LM.   +6 more
europepmc   +1 more source

Polo-Like Kinase 1 Phosphorylation Tunes the Functional Viscoelastic Properties of the Centrosome Scaffold. [PDF]

Adv Sci (Weinh)
Amato M, Hwang JH, Rios MU, Familiari NE, Rosen MK, Woodruff JB.   +5 more
europepmc   +1 more source

Functional and structural impacts of oncogenic missense variants on human polo-like kinase 1 protein. [PDF]

Front Bioinform
Munieswaran G, Manickam V.
europepmc   +1 more source

A Mouse Model of Partial Pancreas Agenesis Induced by Polo-like kinase 1 Mutation. [PDF]

FASEB J
Chen X, Jia Z, Kuang S.
europepmc   +1 more source

Polo-like kinase 5 is lowly expressed and negatively correlates with poorer differentiation, and its positivity may predict a better prognosis in patients with colorectal cancer. [PDF]

Discov Oncol
Fan X, Liu X, Hu Y, Zhen J, Zhang X.
europepmc   +1 more source

Low expression of polo-like kinase 2 predicts high postoperative seizure recurrence in glioma-related epilepsy. [PDF]

Am J Transl Res
Ma H, Lin X, Liu J, Liu X, Chen L, Liang G, Fan D.   +6 more
europepmc   +1 more source

Polo-Like Kinase 1 Expression in Colorectal Cancer: Association With RAS Mutations. [PDF]

Cancer Sci
Tanaka Y, Oki E, Nakanishi R, Kawazoe T, Kudo K, Zaitsu Y, Hisamatsu Y, Ando K, Oda Y, Yoshizumi T.   +9 more
europepmc   +1 more source

Polo-like kinase 1 maintains transcription and chromosomal accessibility during mitosis. [PDF]

Mol Biol Cell
Shen Z, Adams K, Moreno R, F Lera R, Kaufman E, Lang JD, E Burkard M.   +6 more
europepmc   +1 more source

Integrative analysis of polo-like kinase family identifies a prognostic signature and validates PLK2 as a therapeutic target in glioma. [PDF]

Transl Cancer Res
Zheng C, Chen Q, Fang Z, Zhang D, Feng Y, Yu S, Zhang Y, Bao Z.   +7 more
europepmc   +1 more source